Stem Cell Research (Dec 2023)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene

  • Omer Hatim,
  • Ivan Pavlinov,
  • Miao Xu,
  • Kaari Linask,
  • Jeanette Beers,
  • Chengyu Liu,
  • Karsten Baumgärtel,
  • Melissa Gilbert,
  • Nancy Spinner,
  • Catherine Chen,
  • Jizhong Zou,
  • Wei Zheng

Journal volume & issue
Vol. 73
p. 103231

Abstract

Read online

Alagille syndrome (ALGS) is an autosomal dominant, multisystemic disorder due to haploinsufficiency in either the JAG1 gene (ALGS type 1) or the NOTCH2 gene (ALGS type 2). The disease has been difficult to diagnose and treat due to its muti-system clinical presentation, variable expressivity, and prenatal onset for some of the features. The generation of this iPSC line (TRNDi032-A) carrying a heterozygous mutation, p.Cys682Leufs*7 (c.2044dup), in the JAG1 gene provides a means of studying the disease and developing novel therapeutics towards patient treatment.

Keywords